Fidelity SPDR Advertisement
Home > Boards > Stock Clubs > Market Trends and Strategies > $heff's $tation of $tocks & $olid DD

TLON..$.935 Will be revisiting this one as well

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
$heff Member Profile
Member Level 
Followed By 3,263
Posts 27,484
Boards Moderated 1
Alias Born 07/08/06
160x600 placeholder
Oregon Initiative Seeks Lower Pot Taxes Than Cities Want
As voters in this state prepare to decide whether to legalize recreational marijuana, a dispute over taxing the drug is demonstrating the complexity of transforming a black market into a legal one.
European Markets Show Signs of Stress--2nd Update
Microsoft Gains Help Lead Tech's Advance
Treasury Bonds Pull Back for Second Straight Day
Will Free Data Become the Next Free Shipping?
Microsoft Braces for Another Nokia Hit--Earnings Preview
Procter & Gamble Looking at Margins, Brands--Earnings Preview
Stifel Financial to Hire Two Former Merrill Lynch Advisers
Pfizer Results Will Play Second Fiddle to Dealmaking Outlook -- Earnings Preview
U.S. Stocks Gain, but IBM Weighs on Dow
$heff Member Level  Friday, 02/24/12 03:23:01 PM
Re: $heff post# 52072
Post # of 83799 
TLON..$.935 Will be revisiting this one as well this weekend and posting some good information (article from Nov 2011) I came across on "accelerated approvals". Really strong in favor of what TLON is doing during this FDA process. Whether they enroll a patient on the Phase III conf study is important. I think it adds "icing" to the cake. Even without that, the study has been initiated. The FDA has indicated they want to see patient enrollment at the time of approval (5/13) so that would be the most important thing for the company.

Sheff's Station...All Aboard...Sign Up Here!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist